Evidence map›Paper›PMID 32289101›Full record

ArticleMaterials today. Chemistry2019

Metal complexes driven from Schiff bases and semicarbazones for biomedical and allied applications: a review.

M S More, P G Joshi, Y K Mishra, P K Khanna

Open access · bronzeAbstract read
In one paragraph

Article in Materials today. Chemistry, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 60 papers.

0numbers the graph read from it
0cells of the map it votes in
60citing papers in PubMed
14.4field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

60 citing papers in PubMed, 373 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Review
  7. Article
  8. Review
  9. Review
  10. Article
  11. Article
  12. Green synthesis,Future medicinal chemistry · 2025
    Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. [Pharmaceutics · 2025
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 3 countries.

M S MoreNanochemistry/QDs R & D Laboratory, Department of Applied Chemistry, Defence Institute of Advanced Technology (DIAT), Ministry of Defence, DRDO, Government of India, Girinagar, Pune, 411025, India.
P G JoshiNanochemistry/QDs R & D Laboratory, Department of Applied Chemistry, Defence Institute of Advanced Technology (DIAT), Ministry of Defence, DRDO, Government of India, Girinagar, Pune, 411025, India.
Y K MishraInstitute for Materials Science, Kiel University, Kaiserstrasse. 2, Kiel, 24143, Germany.
P K KhannaNanochemistry/QDs R & D Laboratory, Department of Applied Chemistry, Defence Institute of Advanced Technology (DIAT), Ministry of Defence, DRDO, Government of India, Girinagar, Pune, 411025, India.
Defence Institute of Advanced Technology · INUniversity of Southern Denmark · DK

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Schiff bases are versatile organic compounds which are widely used and synthesized by condensation reaction of different amino compound with aldehydes or ketones known as imine. Schiff base ligands are considered as privileged ligands as they are simply synthesized by condensation. They show broad range of application in medicine, pharmacy, coordination chemistry, biological activities, industries, food packages, dyes, and polymer and also used as an O

Indexed as

2,6-DAPBPTSC, 2,6-diacetylpyridine bis-4-phenyl-3-thiosemicarbazone35-DTBP, 3,5-di-tert-butylphenol3CLpro, 3C-like proteaseATNR, Amine terminated liquid natural rubberATT, 2-acetylthiophene thiosemicarbazoneBBPT, Biacetyl bis(4-phenyl-3-thiosemicarbazone)BBTSC, Benzyloxybenzaldehyde thiosemicarbazoneBCG, Bacillus calmette-guérineBDT, BenzyldithiosemicarbazoneBGPT, Bipyridyl glyoxal bis(4-phenyl-3-thiosemicarbazone)Biological/biomedical activitiesBipy, 2,2-bipyridineBMTS, Biacetyl monothiosemicarbazoneCT DNA, Calf thymus deoxyribonucleic acidDAPY, 2,3-diamino-pyridineDTBP, 2,6-di-tert-butylphenolDTBQ, 2,6-di-tert-butyl-4,4′-benzoquinoneEAC, Enrichlish Ascitices CellsHEK-293, Human Embryonic Kidney cellsHeLa, immortal cell linesHepG2, Hepatic cellular carcinoma cells (Human liver cancer cell line)HL-60, Human leukemia-60 cell lineIgG, Immunoglobin GK B HCT-8, Human colon cancer cell lineMCF7 cells, Michigan Cancer Foundation-7 (breast cancer cell line)MCF-7, Michigan Cancer Foundation-7Metal complexesMHV, Mouse hepatitis virusM-IBDET, N-methylisatin-β-4′,4′-diethylthiosemicarbazoneMLV, Moloney leukemia virusMSOPD, N,N-bis(3-methylsalicylidene)-ortho-phenylenediamineNQSC, Naphthoquinone semicarbazoneNQTS, ortho-Naphthoquinone thiosemicarbazoneOLED, Organic light emitting diodePAS, p-amino salicylic acidPhen, 1,10-phenanthrolinePPTS, Picolinealdehyde-4-phenyl-3-thiosemicarbazoneSARS CoV, Severe Acute Respiratory Syndrome coronavirusSARS, Severe acute respiratory syndromeSB-HAG, Schiff bases of hydroxyamino guanidinesscCO2, Super-critical carbon dioxideSchiff baseSemicarbazoneSK-MEL-30, Human Melanoma Cell LineSK-OV-3 cells, Ovarian cancer cell lineSSB-HAG, salicylaldehyde Schiff bases of HAGTCIDw, Tissue culture Infective DoseTTBDQ, 3,5,3′,5′-tetra-tert-butyl-4,4′-diphenoquinoneVSV, vesicular stomatitis virus

Identifiers

PMID32289101
PMCPMC7110249
OpenAlexW2991003930

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.